363587-67-1 Usage
General Description
N-tert-Butyl-2-nitrobenzenesulfonaMide, 97% is a chemical compound with a purity of 97% that is commonly used as a reagent in organic synthesis. It is a versatile building block in the pharmaceutical and agrochemical industries, with applications in the synthesis of various biologically active compounds. N-tert-Butyl-2-nitrobenzenesulfonaMide, 97% is known for its high reactivity and stability, making it a valuable tool in the production of complex organic molecules. Its nitro group and sulfonamide functionality provide it with unique properties that make it useful in a wide range of chemical reactions. Overall, N-tert-Butyl-2-nitrobenzenesulfonaMide, 97% is a highly useful and versatile compound in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 363587-67-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,3,5,8 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 363587-67:
(8*3)+(7*6)+(6*3)+(5*5)+(4*8)+(3*7)+(2*6)+(1*7)=181
181 % 10 = 1
So 363587-67-1 is a valid CAS Registry Number.
363587-67-1Relevant articles and documents
One-pot synthesis ofN-substituted benzannulated triazolesviastable arene diazonium salts
Faggyas, Réka J.,McGrory, Rochelle,Sutherland, Andrew
supporting information, p. 6127 - 6140 (2021/07/21)
A mild and effective one-pot synthesis of 1,2,3-benzotriazin-4(3H)-ones and benzothiatriazine-1,1(2H)-dioxide analogues has been developed. The method involves the diazotisation and subsequent cyclisation of 2-aminobenzamides and 2-aminobenzenesulfonamidesviastable diazonium salts, prepared using a polymer-supported nitrite reagent andp-tosic acid. The transformation was compatible with a wide range of aryl functional groups and amide/sulfonamide-substituents and was used for the synthesis of pharmaceutically important targets. The synthetic utility of the one-pot diazotisaton-cyclisation process was further demonstrated with the preparation of an α-amino acid containing 1,2,3-benzotriazin-4(3H)-one.
